AAKRITI ARORA

GREENVILLE, NC NPI 1528680279

General Payments — all program years on this page

$645.67

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $413.87 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $343.8814
Education $69.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $173.745
Alexion Pharmaceuticals, Inc. $108.813
Exelixis Inc. $46.862
E.R. Squibb & Sons, L.L.C. $27.552
Acerta Pharma LLC $21.041
ABBVIE INC. $19.701
PFIZER INC. $16.171

By program year

Program yearAmountRecords
2023 $231.805
2024 $413.8715

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101320676 E.R. Squibb & Sons, L.L.C. $14.31 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101320688 E.R. Squibb & Sons, L.L.C. $13.24 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103241615 ABBVIE INC. $19.70 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110510718 Alexion Pharmaceuticals, Inc. $69.99 03/19/2024 Education Undisputed 01/23/2026 View at CMS
1110511292 Alexion Pharmaceuticals, Inc. $18.09 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110513138 AstraZeneca Pharmaceuticals LP $21.04 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110515520 Alexion Pharmaceuticals, Inc. $20.73 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131365772 PFIZER INC. $16.17 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138554196 Exelixis Inc. $16.76 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138554198 Exelixis Inc. $30.10 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141709749 Merck Sharp & Dohme LLC $13.54 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141709751 Merck Sharp & Dohme LLC $26.28 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141872753 Merck Sharp & Dohme LLC $13.21 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141872755 Merck Sharp & Dohme LLC $105.07 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141932173 Merck Sharp & Dohme LLC $15.64 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.